Together, these data support a role for heightened SHH/smoothened signaling, in concert with TGF-β1, in the downregulation of FGF-10 gene expression observed in MSCs of human IPF subjects with progressive disease. The gene discussed is SHH; the disease is idiopathic pulmonary fibrosis.